R.M. Mohammad
Karmanos Cancer Institute
Wayne State University School of Medicine
Department of Medicine
Detroit
USA
Name/email consistency: high
- Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies. Mohammad, R.M., Katato, K., Almatchy, V.P., Wall, N., Liu, K.Z., Schultz, C.P., Mantsch, H.H., Varterasian, M., al-Katib, A.M. Clin. Cancer Res. (1998)
- Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1. Mohammad, R.M., Varterasian, M.L., Almatchy, V.P., Hannoudi, G.N., Pettit, G.R., Al-Katib, A. Clin. Cancer Res. (1998)